In part 2 of our digital supplement, the brightest ophthalmology stars profess their feelings for the ASCRS Congress
| 5 min read
In our new ARVO Member Limelight section, we talk to Gary D. Novack about his career, ARVO, and an Enterprising (!) approach to research
| 4 min read
The latest and greatest research in vision was showcased at ARVO 2022 – here’s our breakdown of the poster winning research
Hannah C. Lamont
Disease research should embrace the biotechnology available to increase drug development success
Sitting Down With… Douglas Koch, Professor and Allen, Mosbacher, and Law Chair in Ophthalmology, Cullen Eye Institute, Baylor College of Medicine
The Ophthalmologist editorial team answers your questions about The Power List selection process
Following the publication of The Ophthalmologist Power List 2022, we share your overwhelmingly positive feedback
The what, where, who, and how many times of the 2022 List
Is there a more efficient approach to treat glaucoma patients who cannot maintain eye drop adherence?
Are we blind to the impact that improved eye health could have on the world?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Light Up Your Life
Bridging the App
It’s a Drug’s Life